Team Neobiomics was thrilled to be participating in a conference in Italy, for the second time! Neobiomics exhibited at the jENS 2023: 5th Congress of Joint European Neonatal in Rome and was represented by Dr Stefan Johansson, CEO and Founder of Neobiomics, Vera Westin, PhD… Read More »Team Neobiomics at the jENS conference in Rome!
We are thrilled to announce a significant milestone for our company as we proudly confirm our first successful orders from prestigious hospitals in Belgium and Italy. This marks a momentous achievement and a pivotal step forward in our mission to provide high-quality products globally. ProPrems®… Read More »First Orders from Belgium and Italy
Stockholm July 21, 2023 – Neobiomics and Bios Therapeutics have entered into aDistribution Agreement under which Bios Therapeutics has the exclusive rights to register, market and sell Neobiomics’ proprietary product ProPrems® in Greece. ProPrems® is a high-quality product for safe food supplementation with one billion… Read More »Neobiomics AB and BIOS THERAPEUTICS announce an exclusive collaboration for distribution of ProPrems® in Greece
Team Neobiomics was thrilled to be participating at ICCN, for the first time! Neobiomics exhibited at the 11th International Conference on Clinical Neonatology (ICCN) in Turin, Italy and was represented by Dr Stefan Johansson, CEO and Founder of Neobiomics and Carla Martino, Regional Sales Manager… Read More »Team Neobiomics at the ICCN conference in Italy
Team Neobiomics was thrilled to be participating for the first time at the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) conference in Athens, Greece. We had a great time meeting and interacting with the other participants from around the world. This gave us… Read More »Team Neobiomics at ESPNIC & REaSoN Conference